METGEN OY

MetGen Oy is an innovative biotech SME which designs, develops, supplies, and markets novel enzymatic solutions and technologies around them to meet our customer specific needs. MetGen was found in 2008 and is based in Kaarina, Finland. MetGen’s enzyme products – MetZyme®- are industrial, highly-active, natural catalyst that accelerate chemical reactions. They can survive in harsh industrial environments which enables novel applications and combination with other enzymes. MetGen uses advances in genetic engineering and microbiology to adapt enzymes to harsh industrial conditions and to handle a variety of lignocellulosic substrates. MetGen has invented two disruptive technologies: ENZINE® to develop industrial enzymes and METNIN™ to valorize lignin, to significantly contribute to the economics and sustainability of process industries such as pulp & paper, biofuels and biochemicals. With ENZINE® technology platform, MetGen has achieved successful industrial trials with sector leaders in forest and renewable chemicals and aims to be a widely recognized supplier of industrial enzymes. The lignin refining technology METNIN™ enables the production of tailored and highly functional lignin material for different application areas including packaging, films and foams.

Role in BIONEER: MetGen will lead WP3, focusing on the chemical and enzymatic tailoring of carbohydrate-based compounds. Specifically, enzymes developed during the project will be upscaled and supplied to meet the ongoing demand. Additionally, MetGen will employ its METNIN^TM lignin refining process at pilot scale to process and valorize the lignin side stream fractions produced from the lignocellulosic biomass processed in the project.